Form 4: CoreWeave CDO Sells Shares via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, reported the sale of Class A Common Stock on January 5, 2026, through pre-arranged 10b5-1 trading plans.

Summary

• Brannin McBee, CoreWeave's Chief Development Officer, reported multiple transactions on January 5, 2026, involving the conversion and sale of Class A Common Stock.
• A total of 102,835 Class A shares were acquired through conversion of Class B stock and subsequently sold directly by Mr. McBee at weighted average prices ranging from $77.4705 to $84.0464.
• An additional 25,000 Class A shares were acquired and sold by the Brannin J. McBee 2022 Irrevocable Trust, with prices ranging from $77.4704 to $84.0453.
• The Canis Major 2024 Irrevocable Trust LLC also acquired and sold 3,000 Class A shares, with prices ranging from $77.5276 to $82.84.
• All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
• Following these transactions, Mr. McBee directly holds 248,664 Class A Common Stock and 8,808,650 Class B Common Stock.
• The Brannin J. McBee 2022 Irrevocable Trust holds 4,116,020 Class B Common Stock, and the Canis Major 2024 Irrevocable Trust LLC holds 342,000 Class B Common Stock.
• This Form 4 is Part 1 of 3 for Mr. McBee, indicating further transactions will be reported.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While insider selling can be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns that the sales are based on new, undisclosed negative information. It's a planned liquidity event.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment strategy rather than a reaction to new, undisclosed negative information.

Negatives

• Significant insider selling, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.

Future Outlook

NA

Industry Context

This filing reflects routine insider stock transactions for a publicly traded company. Such pre-planned sales are common for executives managing their personal portfolios and liquidity, especially in high-growth technology sectors where compensation often includes significant equity.

Related Party Transactions

• Sales of Class A Common Stock were conducted by the Brannin J. McBee 2022 Irrevocable Trust, where the reporting person's spouse is trustee and beneficiaries include the spouse and minor child.
• Sales of Class A Common Stock were conducted by the Canis Major 2024 Irrevocable Trust LLC, where the reporting person serves as manager.

Stakeholder Impact

• Shareholders: May perceive insider selling as a negative signal, though the 10b5-1 plan reduces the severity of this perception. The overall impact on share price will depend on market interpretation and the volume of sales relative to total outstanding shares.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

• Further transactions by the reporting person are expected to be reported in Parts 2 and 3 of this Form 4 filing.

Key Dates

Recommendation

While significant insider selling typically warrants caution, these transactions were executed under a pre-arranged 10b5-1 plan, which suggests a planned liquidity event rather than a reaction to adverse company developments. Investors should monitor subsequent filings (Parts 2 and 3) and overall company performance, but this specific filing alone does not present a strong 'sell' signal, nor does it provide new information to warrant a 'buy' beyond existing fundamentals.

Keywords

CoreWeave, CRWV, Insider Trading, Form 4, Brannin McBee, Stock Sale, 10b5-1 Plan, Chief Development Officer, Equity Sales, Trust Transactions